ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS

News

IK Investment Partners acquires Ondal Medical Systems

3. Decem­ber 2019

Hamburg / Hünfeld — IK Invest­ment Part­ners (“IK”) announ­ced today that the IK VIII Fund has signed an agree­ment to acquire Ondal Holding GmbH (“Ondal” or “the Company”) from funds advi­sed by Capvis. Ondal is a leading ODM (“Origi­nal Design Manu­fac­tu­rer”) manu­fac­tu­rer of stret­cher systems for the medi­cal equip­ment sector, mainly used in opera­ting rooms and inten­sive care units.

Ondal was foun­ded in 1945 and has since become the world’s leading supplier of stret­cher systems for medi­cal use. With its inno­va­tive and diver­si­fied product port­fo­lio used in opera­ting rooms, inten­sive care units, and diagnostic and imaging faci­li­ties, Ondal sets the global quality stan­dard for relia­bi­lity, func­tio­n­a­lity, and hand­ling. Products manu­fac­tu­red by Ondal are inter­na­tio­nally certi­fied and appro­ved for use in a variety of regu­la­ted markets. The company, which is head­quar­te­red in Hünfeld and has more than 500 employees, opera­tes three produc­tion faci­li­ties in Germany, the USA and China.

Bernd Fabian, CEO of Ondal, said: “With our high-quality systems, we ensure the mobi­lity and avai­la­bi­lity of medi­cal equip­ment, crea­ting opti­mal working condi­ti­ons. On this basis, we have built up long-stan­­ding rela­ti­ons­hips with inter­na­tio­nally active blue chip compa­nies. The team at IK is the ideal part­ner for the next phase of our deve­lo­p­ment due to their exten­sive expe­ri­ence in the medi­cal tech­no­logy market, and shares our posi­tive assess­ment of our company’s growth prospects. We would like to take this oppor­tu­nity to thank Capvis for its support over the past years.”

Anders Peters­son, Part­ner at IK Invest­ment Part­ners, added: “Ondal is the world’s leading plat­form for medi­cal weara­ble systems with an excel­lent repu­ta­tion as a reli­able and stra­te­gic part­ner to medi­cal tech­no­logy compa­nies. We look forward to working with manage­ment to further deve­lop the company’s strong market posi­tion as a tech­no­logy leader in its product segment.”

With Ondal, the mid-cap fund IK VIII acqui­res its fourth invest­ment in the current year. Over­all, this is the fifte­enth acqui­si­tion announ­ced since the fund’s incep­tion. The parties have agreed not to disc­lose the finan­cial details of the transaction.

Parties and advi­sors invol­ved in the transaction:

IK Invest­ment Part­ners: Anders Peters­son, Adrian Tanski, Daniel-Vito Günther
Finan­cial Advi­sor Buyer: Quar­ton (Konstan­tin Schön­born, Rolf Holtmann)
Stra­te­gic Due Dili­gence Buyer: Alva­rez & Marsal (Georg Hochleitner)
Finan­cial Due Dili­gence Buyer: Eight Advi­sory (Michael Wahl)
Legal Advi­sor Buyer: Renzen­brink & Part­ner (Ulf Renzenbrink)
Capvis: Eric Trüeb, Leif-Niklas Fanter
Finan­cial Advi­sor Seller: William Blair (Phil­ipp Mohr, Eike Dickmann)
Legal Advi­sor Seller: Henge­ler Müller (Daniel Wiegand)

About Ondal Medi­cal Systems
Ondal is one of the world’s leading desi­gners and manu­fac­tu­rers of medi­cal weara­ble systems that support move­ment, carry loads and provide light, gas or data to medi­cal equip­ment. www.ondal.de

About IK Invest­ment Partners
IK Invest­ment Part­ners is a Euro­pean private equity firm with an invest­ment focus on the Nordic coun­tries, the DACH region and France/Benelux. Since 1989, IK has laun­ched funds with a cumu­la­tive equity volume of more than 10 billion euros and inves­ted in more than 130 Euro­pean compa­nies. The IK Funds support compa­nies with signi­fi­cant growth poten­tial and their manage­ment teams in deve­lo­ping busi­ness models for the future, streng­t­he­ning the compa­nies’ market posi­tion and thus crea­ting outstan­ding long-term deve­lo­p­ment poten­tial. www.ikinvest.com

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de